Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA. 27—a randomized controlled phase III trial
PE Goss, JN Ingle, KI Pritchard, MJ Ellis… - Journal of clinical …, 2013 - ascopubs.org
Purpose In patients with hormone-dependent postmenopausal breast cancer, standard
adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and …
adjuvant therapy involves 5 years of the nonsteroidal aromatase inhibitors anastrozole and …